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Mediators of monocyte migration, complement receptor-3 (CR3), and chemokine ligand-4 (CCL4) were measured in response to
recovery modalities following resistance exercise. Thirty resistance-trained men (23.1±2.9 y; 175.2±7.1 cm; 82.1±8.4 kg) were given
neuromuscular electric stimulation (NMES), cold water immersion (CWI), or control (CON) treatments immediately following
resistance exercise. Blood samples were obtained preexercise (PRE), immediately (IP), 30 minutes (30 P), 24 hours (24 H), and 48
hours (48 H) after exercise for measurement of circulating CCL4 and CR3 expression on CD14+ monocytes, by assay and flow
cytometry. Circulating CCL4 showed no consistent changes. Inferential analysis indicated that CR3 expression was likely greater in
CON at 30 P than NMES (90.0%) or CWI (86.8%). NMES was likely lower than CON at 24 H (92.9%) and very likely lower at 48 H
(98.7%). Expression of CR3 following CWI was very likely greater than CON (96.5%) at 24 H. The proportion of CR3+ monocytes
was likely greater following CWI than NMES (85.8%) or CON (85.2%) at 24 H. The change in proportion of CR3+ monocytes was
likely (86.4%) greater following NMES than CON from IP to 30 P. The increased expression of CR3 and increased proportion of
CR3+ monocytes following CWI at 24 H indicate a potentially improved ability for monocyte adhesion to the endothelium, possibly
improving phagocytosis of damaged tissues.

1. Introduction
Skeletal muscle damage resulting from resistance exercise
stimulates an inflammatory cascade initiated by cytokines [1].
In addition to the increases in markers of muscle damage
like creatine kinase (CK) and myoglobin, the inflammatory
responses to resistance exercise includes, among many others,
increases in tumor necrosis factor-𝛼 (TNF-𝛼), interleukin10 (IL-10), and C-reactive protein (CRP) [1–4]. During the
inflammatory process, the cell adhesion molecule complement receptor 3 (CR3), consisting of the integrin molecules
cluster of differentiation (CD)11b and CD18 [5], facilitates
monocyte vascular adhesion and migration into the damaged
tissue, thereby promoting phagocytosis of opsonized particles [5, 6]. Prior to extravasation, monocytes are signaled
to the site of inflammation, primarily through chemotaxis
[7]. During chemotaxis, several chemokines are secreted,
including macrophage inflammatory protein-1𝛽, also known
as chemokine ligand 4 (CCL4) [8]. While the actions of CCL4

and CR3 on leukocytes are not fully understood, previous
research has shown increases in CCL4 concentration [9] and
CR3 expression following exercise [10]. Many other studies,
however, have found equivocal results [11–13]. Additionally,
whether these processes can be altered by athletic training
therapies following muscle damaging exercise is presently
unknown.
Cold water immersion (CWI) therapy is a common
recovery modality utilized to assist athletes in recovery from
high intensity exercise [14]. CWI can alleviate delayed onset
muscle soreness (DOMS) and reduce the efflux of creatine
kinase (CK) up to 48 hours following exercise [14]. CWI has
also been demonstrated to decrease postexercise leukocytosis
or increase the number of leukocytes, specifically, polymorphonuclear cells and lymphocytes, in response to muscle
damage [15, 16]. CWI has been demonstrated to modulate
cytokine and chemokine activity [4, 17], while cold exposure
in vitro has shown to increase the expression of cell adhesion molecules, specifically the 𝛽2-integrin CD11b/CD18, on
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cultured neutrophils [18], which may mediate phagocytic
migration [5]. However, in vivo examination of the influence
of CWI on the processes of monocyte cell adhesion is yet to
be demonstrated.
Neuromuscular electrical stimulation (NMES) is another
recovery modality intended to increase blood flow to the
inflamed tissue [19, 20]. Despite the minimal benefits to
strength and power recovery [19, 21], NMES may be beneficial
for removal of metabolic waste [22] and reducing circulating
levels of CK [21]. Recent work from our lab has indicated that
the use of NMES suppressed the natural increase in TNF𝛼 receptor-1 on monocytes 30 minutes after exercise which
remained for 48 hours following an acute heavy resistance
training bout [3], indicating a modulation of the immune
response. However, how NMES potentially intervenes during
the postexercise monocyte cell adhesion cascade is yet to be
determined.
Investigation of the expression of CR3 on monocytes
and concomitant circulating concentrations of CCL4 during
recovery from muscle damaging exercise will help us to
better understand the processes and mechanisms of exerciseinduced muscle damage and subsequent repair. Additionally,
examining how recovery modalities mediate the cell adhesion
response may provide specific evidence supporting various
strategies used to facilitate recovery. To our knowledge, this
will be the first study to examine the impact of a dynamic
strength training session on CCL4 and CR3. Therefore, the
purpose of this study was twofold. First, we examined the
circulating CCL4 and CR3 responses to acute high volume
resistance exercise. Secondly, we examined the influence of
two recovery methods (NMES and CWI) following resistance
exercise on the concentration of the chemokine CCL4 and
expression and proportion of CR3+ cells.

2. Methods
2.1. Participants. Thirty resistance-trained males volunteered
to participate in this study. Participants were randomly
divided into three treatment groups: control (CON) (𝑛 = 10),
neuromuscular electrical stimulation (NMES) (𝑛 = 10), and
cold water immersion (CWI) (𝑛 = 10). Subjects’ characteristics are depicted in Table 1. Following an explanation of
all procedures, risks, and benefits, each participant gave his
written informed consent prior to participation in this study.
The Institutional Review Board of the university approved the
research protocol. For inclusion in the study, participants had
to have a minimum of one year of resistance training experience, particularly in the squat exercise. Participants were not
permitted to use any additional nutritional supplements or
medications while enrolled in the study. Screening for nutritional supplements and performance enhancing drug use was
accomplished via a health history questionnaire completed
during participant recruitment. Participants were instructed
not to partake in any additional recovery strategies while
enrolled in the study including NSAIDs, saunas, stretching
routines, foam rollers, massages, and additional hot/cold
water therapy.
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Table 1: Subject characteristics.
𝑛
Age (y)
Height (cm)
Weight (kg)
BMI

NMES
10
23.0 ± 3.0
175.9 ± 7.6
83.5 ± 9.8
27.0 ± 2.55

CWI
10
22.5 ± 3.0
171.4 ± 6.6
77.1 ± 7.7
26.5 ± 2.13

CON
10
23.8 ± 3.0
178.3 ± 5.6
85.7 ± 5.4
27.0 ± 2.44

Descriptive characteristics of participants in neuromuscular electrical stimulation (NMES), cold water immersion (CWI), and control (CON).

2.2. Study Protocol. Participants reported to the Human
Performance Laboratory (HPL) on four separate occasions.
On the first visit (T1), participants were tested for maximal
strength (1-RM) on the barbell back squat, dead lift, and
barbell split squat exercises. Prior to the second visit (T2),
which occurred at least 72 hours after T1, participants were
instructed to refrain from all forms of exercise for a minimum
of 72 hours. Also, prior to subsequent exercise sessions,
participants were instructed to report to the HPL in a 10hour fasted state. During T2, participants performed a lower
body resistance exercise session which consisted of four sets
of the squat, dead lift, and barbell split squat exercises. The
rest interval between each set and between all exercises was
90 s. The squat exercise was performed with 80% of the
participant’s previously measured 1-RM, while the dead lift
and barbell split squat exercises were performed with 70%
of the participant’s previously measured 1-RM. Participants
were encouraged to perform as many repetitions as possible,
but not to exceed 10 repetitions in any set. This protocol
was utilized to simulate a typical high intensity lower body
training routine during a hypertrophy phase of training.
Participants then reported back to the HPL 24 (T3) and 48
hours (T4) after exercise. During T3 and T4, participants
performed four sets of the squat exercise only using the same
loading pattern and rest interval length as T2 to monitor
strength and power. Participants were asked to complete
dietary logs during the two days of recovery. Blood samples
were obtained at five time points over the course of the study:
baseline (BL), immediately after exercise (IP), and 30 min
after exercise (30 P) during T2 and 24 (prior to exercise on
T3) and 48 hours (prior to exercise on T4) after T2 (24 H and
48 H, resp.). All trials started between 7 and 9 AM with each
individual starting at the same time of day. This allowed blood
samples obtained prior to exercise to be collected within 15
minutes of the previous day.
2.3. Neuromuscular Electrical Stimulation Therapy (NMES).
Participants assigned to NMES were provided with 24
minutes of electrical stimulation immediately following the
postexercise blood draw (T2) or after exercise (T3) using
a commercially available product. All treatments were provided according to the manufacturer’s instructions (Compex
Performance US, DJO, Vista, CA). Briefly, the participant
was placed in a supine position with three electrodes placed
on each of the quadriceps. Specifically, one large electrode
with a negative charge was placed at the most proximal point
of the upper leg, while two small electrodes with positive
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charge were placed on the belly of the vastus lateralis and
vastus medialis. The unit was set to an established recovery
mode, while the participants were asked to increase the
stimulation intensity to the highest possible level without
undue discomfort. The research team observed the participants during stimulation to assist with proper intensity of
stimulation while also recording the stimulation setting as
previously noted [23]. The treatment protocol consisted of
nine sequences, with the first three stages lasting for two
minutes and the remaining six for three minutes. Frequency
of contraction started at 9 Hz, stepping down 1 Hz per stage
to 1 Hz. The participants were asked to remain in a supine
position throughout the 24 minutes of treatment.
2.4. Cold Water Immersion (CWI). The participants in CWI
were required to fully immerse their lower body into a metal
tub (58.4 cm × 121.9 cm) filled to 22.9 cm of height with ice
water at 10∘ –12∘ C immediately following postexercise blood
draw (T2) or immediately after exercise (T3). Participants
sat in the water up to their umbilicus for 10 min. Once the
participants completed the 10 minutes in the ice bath they
were asked to remain in the HPL for an additional 20 minutes
to ensure a similar postexercise intervention opportunity
with NMES and CON, who remained in the HPL for 30
minutes in a supine position.
2.5. Blood Measurements. During T2, PRE blood samples
were obtained following a 15 min equilibration period.
Additional blood samples were also drawn at IP and 30 P. All
blood samples were obtained using a Teflon cannula placed
in a superficial forearm vein using a three-way stopcock with
a male luer lock adapter. The cannula was maintained patent
using an isotonic saline solution (Becton Dickinson, Franklin
Lakes, NJ). IP blood samples were taken within 1 minute of
exercise cessation. Following the resistance exercise protocol,
participants remained in the supine position for the full 30
min recovery phase prior to the 30 P blood sample being
drawn, except for the participants in the CWI groups, who
spent the first 10 minutes of the 30 minutes in the ice bath. All
T2 blood samples were drawn with a plastic syringe while the
participant was in a supine position. During T3 and T4, only
preexercise blood samples were drawn (24 H and 48 H, resp.)
following a 15 min equilibration period. These blood samples
were obtained from an antecubital arm vein using a 20-gauge
disposable needle equipped with a Vacutainer tube holder
(Becton Dickinson, Franklin Lakes, NJ). Blood samples of
each participant were obtained at the same time of day during
each session.
All blood samples were collected into two Vacutainer
tubes, one containing no anticlotting agent and the second
containing K2 EDTA. A small aliquot of whole blood was
removed from the second tube and used for determination
of hematocrit and hemoglobin. The blood in the first tube
was allowed to clot at room temperature for 30 minutes
and subsequently centrifuged at 3,000 ×g for 15 min along
with the remaining whole blood from the second tube. The
resulting plasma and serum were placed into separate 1.6-mL
microcentrifuge tubes and frozen at −80∘ C for later analysis.
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2.6. Cell Staining. Samples were obtained from fresh, anticoagulated (K2 EDTA) whole blood and analyzed in duplicate.
Erythrocytes were first lysed from 350 𝜇L of whole blood
with BD Pharm Lyse solution (BD Biosciences, Franklin
Lakes, NJ) within 30 min of collection. Samples were then
washed in staining buffer containing 1 x phosphate-buffered
saline containing fetal bovine serum (BD Pharminigen Stain
Buffer; BD Biosciences) by centrifugation and aspiration
three times. Leukocytes were then resuspended in 100 𝜇L BD
Pharminigen Stain Buffer. Direct staining methods were used
to label CR3 and CD14. Allophycocyanin (APC) conjugated
anti-CR3 (D12; BD Pharminigen) and PerCP Cy5.5 conjugated anti-CD14 (M5E2; BD Pharminigen) were used in the
receptor labeling process. Surface staining was performed by
adding 20 𝜇L of directly conjugated APC-anti-CR3 and 5 𝜇L
of directly conjugated PerCP Cy5.5-anti-CD 14 to the cell
suspension and incubating in the dark for 30 min at 20∘ C.
Cells were resuspended in 1.0 mL of stain buffer for flow
cytometry analysis.
2.7. Flow Cytometry. Flow cytometry analysis of stained cells
was run on a BD C6 Accuri Flow Cytometer (BD Biosciences,
San Jose, CA), equipped with BD Accuri analysis software
(BD Biosciences). Forward and side scatter along with two
fluorescent channels of data were collected using two lasers
providing excitation at 488 and 640 nm. Monocytes were
determined by initial gating based on forward and side
scatter, followed by gating for CD14+ cells as also described
by Tallone and colleagues [24]. A minimum of 10,000 events,
defined as CD14+ monocytes, was obtained with each sample
(Figure 1).
Analysis of monocyte subpopulations was completed by
quadrant analyses, in which CD14 was compared with CR3.
Mean fluorescence of CR3 on CD14+ cells was recorded,
representing the expression of CR3 per cell [25]. Proportion
of CR3+/CD14+ versus CR3−/CD14+ were determined by
quadrant analysis (Figure 1). Compensation for fluorescence
spillover was set based on manufacturer recommendations
(BD Biosciences).
2.8. Biochemical Analysis. Circulating levels of chemokine
(C-C motif) ligand 4 (CCL4), also referred to as macrophage inhibiting protein-1𝛽, were assessed by Magpix
(EMD Millipore, Billerica, MA, USA) via the human cytokine/chemokine panel one (EMD Millipore, Billerica, MA,
USA). Samples were analyzed according to manufacturer’s
guidelines with an average coefficient of variation 6.25%.
Creatine kinase (CK) was analyzed with the use of
a spectrophotometer and a commercially available enzymatic kit (Sekisui Diagnostics, Charlottetown, PE, Canada)
per manufacturer’s instructions. Determination of serum
immunoreactivity values was determined using a BioTek
Eon spectrophotometer (BioTek, Winooski, VT, USA). To
eliminate interassay variance, all samples for a particular
assay were thawed once and analyzed in the same assay run
by a single technician. All samples were run in duplicate with
a mean intra-assay variance of 2.99%.
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Figure 1: Gating procedures for CD14+ cells. (a) CD14+ cells
selected from the specified region based on forward (FSC) and side
scatter (SSC) properties. (b) Two-dimensional histogram displaying
fluorescence characteristics of cells in selected region. Cells positive
for CR3 and CD14 are displayed in the upper right quadrant.

2.9. Dietary Logs. Participants were instructed to record
as accurately as possible everything they consumed during
workout days T2 and T3. Participants were instructed not to
eat or drink (except water) within 10 hours of reporting to
the HPL for subsequent visits. FoodWorks Dietary Analysis
software (McGraw Hill, New York, NY) was used to analyze
the dietary recalls for total kilocalorie intake (kcal) and
macronutrient distributions (carbohydrate, protein, and fat).
2.10. Statistical Analysis. All biochemical changes were
analyzed using a repeated measures analysis of variance

(ANOVA). Pairwise comparisons with the Bonferroni adjustment were employed for significant main effects, while a
Tukey post hoc test was employed for significant interactions.
Prior to analysis all data were assessed to ensure normal distribution, homogeneity of variance, and sphericity. Changes
in dietary composition were analyzed using repeated measures ANOVA. Results were considered significant at an alpha
level of 𝑃 ≤ 0.05. All data are reported as mean ± SD.
The effects of treatment modalities were analyzed using
magnitude-based inferences calculated from 90% confidence
intervals, as previously described by Batterham and Hopkins
[26]. Magnitude based inferences are a statistical approach to
data analysis which uses within-subject modeling as opposed
to combining data into a single unit of change as with
repeated measures. Magnitude based inferences have also
been used previously in conjunction with null hypothesis
testing [2, 4, 27] to allow for more sensitive interpretation,
providing more practically applicable understandings of the
results. Additionally, magnitude based inferences help determine whether a significant 𝑃 value is meaningful, as significant 𝑃 values have been determined to be trivial previously
[27]. Absolute values and changes from IP were analyzed
to assess differences between groups at each individual time
point and across time, respectively. The IP time point was
selected as the initial baseline as no recovery methods had
been employed prior to IP. These values were then analyzed
via a published spreadsheet [28], with the smallest nontrivial
change set at 20% of the grand standard deviation [26].
All data are expressed with percent chances of a beneficial,
trivial, and negative outcome. Qualitative inferences, based
on quantitative chances were assessed as <1% almost certainly
not, 1–5% very unlikely, 5–25% unlikely, 25–75% possibly, 75–
95% likely, 95–99% very likely, and >99% almost certainly
[29].

3. Results
Groups did not differ in baseline physical characteristics.
Average resistance training experience was 6.5 ± 3.5 years,
and participants had an average squat 1RM of 151.0 ± 31.0 kg.
No group differences were noted in the quantity of repetitions
performed, markers of muscle damage (CK) 24 and 48 hours
after exercise, or macronutrient composition on T2 and T3.
Decreases in repetitions from T2 (23.1–27.9) were noted for
all groups combined at T3 (−30%; 14.1–20.9) and T4 (−24%;
15.9–21.8). Additionally, increases in CK concentrations from
PRE (103.4–166.3 U/L) were observed at 24 H (290%; 468.9–
677.1 U/L) and 48 H (272%; 424.6–612.5 U/L). Performance
and nutritional data along with plasma volume shifts have
been previously reported [2]. Results have not been corrected
for plasma volume shifts.
3.1. CCL4 Concentration. No significant difference occurred
between groups at IP (𝑃 = 0.393). Additionally, no significant
main effect for time (𝑃 = 0.317) was observed. Magnitude
based inferences indicate that NMES was likely greater than
CON at IP (percent chance: 80.4%) and 24 H (84.3%). CWI
was possibly greater than CON at IP (73.2%) and 24 H
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Figure 2: Circulating Concentration of CCL4 (mean ± SE). Changes
in CCL4 concentration before exercise (PRE), immediately after
exercise (IP), and 30 minutes (30 P), 24 hours (24 H), and 48
hours (48 H) after exercise in neuromuscular electrical stimulation
(NMES), cold water immersion (CWI), and control (CON) groups.
(a) The value is “likely” greater than CON at the specified time point.
(b) The value is “possibly” greater than CON at the specified time
point.

(65.4%), while it was likely greater (77.7%) at 30 P. When
the change of values was assessed, the changes from IP were
possibly increased in NMES versus CON at 30 P (70.0%),
24 H (52.5%), and 48 H (65.6%). Additionally, changes from
IP were possibly increased in NMES compared to CWI at
24 H (70.7%) and likely greater at 48 H (82.7%). Changes
from IP to 24 H and 48 H were likely (83.6%) and possibly
(64.7%) trivial, respectively, when comparing CON to CWI
(Figure 2).
3.2. CR3 Expression (Reported as Mean Fluorescence) on
CD14+ Monocytes. Mean fluorescence intensity on CD14+
monocytes showed that no significant differences were
observed between groups at IP (𝑃 = 0.269); however, there
was a significant main effect for time (𝑃 = 0.004). Pairwise
comparisons indicate that CR3 was elevated at 30 P compared
to PRE (𝑃 = 0.015), IP (𝑃 = 0.005), and 24 H (𝑃 = 0.005)
(Figure 3).
Magnitude based inferences indicate that CR3 fluorescence on CD14+ monocytes was likely lower following NMES
than CON at IP (85.7%), 30 P (90.0%), and 24 H (92.9%),
while it was very likely lower at 48 H (98.7%). Additionally,
mean fluorescence following CWI was likely lower (86.8%)
than CON at 30 P, while it was very likely greater than
NMES at 24 H (96.5%). Changes in CR3 expression on CD14+
monocytes were unclear for all time points and recovery
modalities (Figure 3).
3.3. Proportion of CR3+ Monocytes (CR3+/CD14+). No difference between groups at IP was observed (𝑃 = 0.690).
Additionally, only a trend for a main effect of time (𝑃 = 0.074)
was observed. Magnitude based inferences indicate that CWI

24000
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a
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a

16000
14000

a, b

c

24 H

48 H

12000
PRE

IP

30 P
Time point

NMES
CWI
CON

Figure 3: Expression of the complement receptor 3 (CR3) on
CD14+ monocytes (mean ± SE). CR3 expression, as measured by
mean fluorescence intensity before exercise (PRE), immediately
after exercise (IP), and 30 minutes (30 P), 24 hours (24 H), and 48
hours (48 H) after exercise in neuromuscular electrical stimulation
(NMES), cold water immersion (CWI), and control (CON) groups.
(a) The value is “likely” lower than CON at the specified time point,
(b) the value is “very likely” lower than CON at the specified time
point, and (c) the value is “very likely” lower than CWI at the
specified time point.

resulted in a likely greater proportion of CR3+ monocytes
than NMES (85.8%) and CON (85.2%) at 24 H (Figure 4).
Additionally, when changes from IP were analyzed, the
increase from IP to 30 P in proportion of CR3+ monocytes
was likely (86.4%) greater in NMES than CON while all other
analyses were unclear.

4. Discussion
The main findings of this investigation indicate that mean
florescence intensity expression of CR3 on CD14+ monocytes
was elevated following an acute bout of heavy resistance
exercise. Recovery treatments appeared to affect both the
expression of CR3 and proportion of monocytes expressing
CR3. Postexercise treatments with NMES and CWI appeared
to attenuate the increased expression of CR3 observed in
CON. Additionally, NMES appears to reduce expression of
CR3 on CD14+ monocytes in comparison to both CWI
and CON at 24 and 48 hours after exercise. Conversely,
NMES likely increased the proportion of circulating CD14+
monocytes expressing CR3 immediately following treatment
compared to the control group. During recovery, CWI likely
resulted in a higher proportion of circulating CD14+ monocytes expressing CR3 at 24 H. Circulating CCL4 showed
large interindividual variation and did not appear to be
consistently affected by the exercise protocol or treatments.
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Figure 4: Proportion of CR3+/CD14+ monocytes (mean ± SE).
Changes in CR3 expression before exercise (PRE), immediately
after exercise (IP), and 30 minutes (30 P), 24 hours (24 H), and 48
hours (48 H) after exercise in neuromuscular electrical stimulation
(NMES), cold water immersion (CWI), and control (CON) groups.
(a) A “likely” lower value than CWI at the specified time point. (b)
A “likely” greater change from IP than CON at the specified time
point.

As CCL4 is a chemotactic cytokine responsible for the
recruitment of monocytes, natural killer cells, and other
immune cells, we had hypothesized that the muscle damaging
exercise would have resulted in significant elevations in CCL4
as part of the cell mobilization process. Similarly, we expected
changes in CCL4 response as a result of blood flow alterations
induced by the treatment modalities. However, contrary
to our hypothesis, circulating CCL4 did not appear to be
strongly influenced by exercise or treatment. While previous
research has shown circulating CCL4 to be elevated in
response to cardiovascular exercise [9], investigations using
resistance exercise similarly found no changes in circulating
CCL4 following eccentric leg extensions [11] and 3 × 6 RM of
the squat, front squat, and leg extension exercise [13]. CCL4
production is stimulated by proinflammatory cytokines (e.g.,
TNF𝛼, IFN𝛾, and IL-1𝛽), while at the same time inhibited
by anti-inflammatory cytokines (e.g., IL-10) [8]. Since we
previously reported that TNF𝛼 and IL-10 were increased 30
minutes following this resistance exercise protocol [2, 4], it
is plausible that the interaction between these pro- and antiinflammatory factors may initiate competing signals leading
to the unclear result observed in this study. However, the large
interindividual variation in circulating CCL4 observed in our
study may have also masked any group trends in the data.
As CCL4 is a chemokine secreted by most immune cells [8],
large differences between individuals are expected and have
been previously demonstrated [30]. Future research should
further investigate the time course of CCL4 concentration
following resistance exercise and how it relates with pro- and
anti-inflammatory factors such as TNF𝛼 and IL-10.
CR3 expression significantly increased 30 minutes following heavy resistance exercise, which returned to baseline

levels approximately 24 hours later. Previous studies examining CR3 expression on monocytes in response to different
exercise protocols have found no increase in receptor expression immediately following exercise [10, 12] but have found
increases during the recovery period [10]. Nevertheless, the
timing of the expression of CR3 on circulating monocytes
appears to be controversial [10, 12]. As monocytes are a
primary source of proinflammatory cytokines following exercise [1], their role in the subsequent inflammatory response
is essential. Typically, granulocytes migrate to the site of
inflammation within hours, while macrophages are observed
to increase in damaged tissue 24 hours following exercise
[31–34]. Monocytes are signaled to the site of inflammation
by chemotaxis and mediated by chemokines [7], which have
been demonstrated to increase following resistance or aerobic
exercise within one hour [9, 35], promoting the monocyte
response. One potential influence on CR3 expression is training status [36]. The resistance-trained individuals recruited to
participate in the present study may have different response
patterns to the training stimulus as compared to nontrained
or recreationally active individuals used in previous investigations [10, 12]. It is possible that higher fitness level will
attenuate the monocytosis observed following exercise [13].
It is important to consider that although the present study
attempted to provide a unique timeline for CR3 expression
changes during 48 hours of recovery, changes could have
occurred between sampling periods that were not measured.
Further studies are needed to identify the time sequence of
CR3 expression in trained and untrained populations.
While both recovery modalities utilized in this study
appear to blunt the postexercise response in CR3 expression
on CD14+ monocytes at 30 P, NMES suppressed CR3 expression on CD14+ monocytes at 24 and 48 hours following the
initial exercise stimulus. To the best of our knowledge, no
prior studies have examined the expression of CR3 in vivo
or on monocytes following CWI. Nash and colleagues [18],
however, have previously demonstrated a gradual increase in
expression of CR3 when cultured neutrophils were cooled
to 10∘ C in vitro. The contrasting results of this study may
be due to a different response in monocytes when cooled.
Alternatively, a reduced leukocytosis following CWI in vivo
[15] may explain the reduced expression of CR3 at 30 P
following CWI. During the postexercise period, monocyte
influx appears to occur with a high expression of CR3 [13,
16]. Our results indicate that CWI may reduce overall CR3
expression at 30 P by blunting the release of monocytes with
elevated CR3 expression. It is important to note, however, that
a decreased leukocytosis following CWI is controversial [37],
and, to the best of our knowledge, no studies have examined
monocyte response following NMES. This emphasizes the
need for further research to determine the source and
impact of reduced expression of CR3 in monocytes following
treatment.
At 24 H, we observed a likely greater proportion of CR3+
monocytes in CWI compared to NMES and CON. While
the proportion of CR3+ cells was consistent with previous
research [10], the difference observed following treatments is
a novel finding. As monocytes typically circulate for several
days [38], the increased proportion of CR3+ monocytes
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observed in this study at 24 H may be a function of increased
expression, which may occur via multiple mechanisms.
Previously, it has been demonstrated that 20 minutes of
exposure to 10∘ C in vitro nearly doubles the expression of
CR3 on granulocytes [18]. It is possible that this may also
occur with monocytes, leading to the observed increase
following CWI. Another potential mechanism is elevation of
C-reactive protein concentrations at 24 hours after exercise
[2] which has been demonstrated to upregulate CD11b and
CD18 [39], which together compose CR3 [5]. Interestingly,
the increases in CR3+ monocytes at 24 H observed in this
study were not observed at 48 H. While being speculative,
it is possible that the increased C-reactive protein may be a
more likely explanation as it followed the same time course
[2]. As IL-10 increases following cold exposure [2], another
potential mechanism would be IL-10 mediated expression
as IL-10 expression has been demonstrated to increase CR3
expression in an animal model [40]. Further research is
warranted to determine whether a greater proportion of
CR3+ cells, or simply CR3 expression, leads to increased
extravasation of monocytes and/or phagocytosis.
Additionally, the change in the proportion of
CR3+/CD14+ cells compared to CR3−/CD14+ cells from IP
to 30 P was likely greater in NMES versus CON. This increase
may be indicative of increased extravasation immediately
following NMES treatment. As NMES treatment increases
blood flow to inflamed tissue [19, 20], observed increases
in the proportion of CR3+ cells may be due to blood flow
changes. It is also possible that NMES affected proportion of
CR3+ cells via cytokine signaling. Recent work from our lab
has indicated that the use of NMES attenuated the increase
in TNF-𝛼 receptor 1 and IL-10 30 minutes following exercise
[2, 3]. Additionally, IL-10 may affect expression of CR3 on
monocytes by way of granulocyte colony stimulating factor
(G-CSF) [41, 42]. Future studies are needed to examine
the mechanisms of NMES during recovery, as well as CR3
expression at additional time points following the cessation
of treatment.
While this is the first study to report changes in adhesion molecules on monocytes following different recovery
modalities after exercise induced muscle damage, several
considerations should be noted in the interpretation of
the results. The first consideration is the training status
of the participants. Resistance-trained men were recruited
for the study to ensure that participants could complete
the strenuous exercise protocol and to avoid potential risks
of implementing the protocol to untrained persons. While
recruitment criteria required that all participants have a minimum training experience of 1 year, there remains the potential
that the relative stress of the protocol varied by individual.
Secondly, the limitations of the blood sampling intervals
must be considered. Following the 30 P sampling time point,
there was almost 24 hours between blood samples. During
this 24-hour period, it is possible that inflammation from
muscle damage and anti-inflammatory effects of therapeutic
modalities may induce changes in cytokine and chemokine
concentrations that may influence CCL4 concentration and
adhesion molecules [12, 43]. Finally, while this investigation
sought to explain mechanisms underlying recovery specific to
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CR3 and CCL4, it is important to keep in mind that several
other inflammatory cells and cytokines are involved in the
recovery process which may impact the actions of CD14+
monocytes. Future studies are needed to examine changes
in cell counts across more frequent sampling during the
recovery period with therapeutic modalities and immune cell
measures.
In conclusion, expression of CR3 on CD14+ monocytes
was elevated following acute muscle damaging resistance
exercise implying an increased potential for each individual
cell to adhere to endothelial walls at 30 minutes after exercise.
By 24 hours into recovery, the elevated expression of CR3
on CD14+ monocytes had returned to baseline. Treatment
with NMES appeared to attenuate the expression of CR3 on
CD14+ monocytes during recovery up to 48 hours, indicating
a reduced potential for cellular endothelial adherence. Additionally, treatment with CWI likely increased the proportion
of CR3+ monocytes. Although we demonstrated exercise
and treatment influences on monocyte CR3 expression, the
subsequent impact of altered expression of CR3 or proportion
of CR3+ cells on extravasation and phagocytosis is not fully
understood.
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K. T. Lappegård, and T. Raastad, “Delayed leukocytosis and
cytokine response to high-force eccentric exercise,” Medicine
and Science in Sports and Exercise, vol. 37, no. 11, pp. 1877–1883,
2005.
[12] F. X. Pizza, B. H. Davis, S. D. Henrickson et al., “Adaptation
to eccentric exercise: effect on CD64 and CD 11b/CD 18
expression,” Journal of Applied Physiology, vol. 80, no. 1, pp. 47–
55, 1996.
[13] B. A. Risøy, T. Raastad, J. Hallén et al., “Delayed leukocytosis
after hard strength and endurance exercise: aspects of regulatory mechanisms,” BMC Physiology, vol. 3, article 14, 2003.
[14] J. Leeder, C. Gissane, K. Van Someren, W. Gregson, and G.
Howatson, “Cold water immersion and recovery from strenuous exercise: a meta-analysis,” British Journal of Sports Medicine,
vol. 46, no. 4, pp. 233–240, 2012.
[15] H. Pournot, F. Bieuzen, R. Duffield, P.-M. Lepretre, C. Cozzolino, and C. Hausswirth, “Short term eVects of various water
immersions on recovery from exhaustive intermittent exercise,”
European Journal of Applied Physiology, vol. 111, no. 7, pp. 1287–
1295, 2011.
[16] S. F. Van Eeden, J. Granton, J. M. Hards, B. Moore, and J. C.
Hogg, “Expression of the cell adhesion molecules on leukocytes
that demarginate during acute maximal exercise,” Journal of
Applied Physiology, vol. 86, no. 3, pp. 970–976, 1999.
[17] N. J. Crystal, D. H. Townson, S. B. Cook, and D. P. LaRoche,
“Effect of cryotherapy on muscle recovery and inflammation
following a bout of damaging exercise,” European Journal of
Applied Physiology, vol. 113, no. 10, pp. 2577–2586, 2013.
[18] G. B. Nash, K. B. Abbitt, K. Tate, K. A. Jetha, and S. Egginton,
“Changes in the mechanical and adhesive behaviour of human
neutrophils on cooling in vitro,” Pflugers Archiv European
Journal of Physiology, vol. 442, no. 5, pp. 762–770, 2001.
[19] N. Babault, C. Cometti, N. A. Maffiuletti, and G. Deley,
“Does electrical stimulation enhance post-exercise performance recovery?” European Journal of Applied Physiology, vol.
111, no. 10, pp. 2501–2507, 2011.
[20] B. F. Miller, K. G. Gruben, and B. J. Morgan, “Circulatory
responses to voluntary and electrically induced muscle contractions in humans,” Physical Therapy, vol. 80, no. 1, pp. 53–60,
2000.
[21] M. Vanderthommen, K. Soltani, D. Maquet, J. M. Crielaard,
and J. L. Croisier, “Does neuromuscular electrical stimulation
influence muscle recovery after maximal isokinetic exercise?”
Isokinetics and Exercise Science, vol. 15, no. 2, pp. 143–149, 2007.

Mediators of Inflammation
[22] F. B. Neric, W. C. Beam, L. E. Brown, and L. D. Wiersma,
“Comparison of swim recovery and muscle stimulation on
lactate removal after sprint swimming,” Journal of Strength
and Conditioning Research/National Strength & Conditioning
Association, vol. 23, no. 9, pp. 2560–2567, 2009.
[23] J. K. Malone, G. F. Coughlan, L. Crowe, G. C. Gissane, and B.
Caulfield, “The physiological effects of low-intensity neuromuscular electrical stimulation (NMES) on short-term recovery
from supra-maximal exercise bouts in male triathletes,” European Journal of Applied Physiology, vol. 112, no. 7, pp. 2421–2432,
2012.
[24] T. Tallone, G. Turconi, G. Soldati, G. Pedrazzini, T. Moccetti, and G. Vassalli, “Heterogeneity of human monocytes:
an optimized four-color flow cytometry protocol for analysis
of monocyte subsets,” Journal of Cardiovascular Translational
Research, vol. 4, no. 2, pp. 211–219, 2011.
[25] M. S. Fragala, W. J. Kraemer, A. M. Mastro et al., “Leukocyte
𝛽 2-adrenergic receptor expression in response to resistance
exercise,” Medicine and Science in Sports and Exercise, vol. 43,
no. 8, pp. 1422–1432, 2011.
[26] A. Batterham and W. Hopkins, “Making meaningful inferences
about magnitudes,” Sportscience, vol. 9, pp. 6–13, 2005.
[27] A. J. Wells, D. H. Fukuda, J. R. Hoffman et al., “Vastus lateralis
exhibits non-homogenous adaptation to resistance training,”
Muscle & Nerve, 2014.
[28] W. G. Hopkins, “A spreadsheet for deriving a confidence
interval, mechanisic inference and clinical inference from a p
value,” Sportscience, vol. 11, pp. 16–20, 2007.
[29] W. G. Hopkins, “Probabilities of clinical or practical significance,” Sportscience, vol. 6, 2002.
[30] H. O. Kim, H.-S. Kim, J.-C. Youn, E.-C. Shin, and S. Park,
“Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays,”
Journal of Translational Medicine, vol. 9, no. 1, article 113, 2011.
[31] J. Peake, K. Nosaka, and K. Suzuki, “Characterization of inflammatory responses to eccentric exercise in humans,” Exercise
Immunology Review, vol. 11, pp. 64–85, 2005.
[32] P. M. Clarkson and M. J. Hubal, “Exercise-induced muscle
damage in humans,” The American Journal of Physical Medicine
and Rehabilitation, vol. 81, no. 11, pp. S52–S69, 2002.
[33] C. Malm, P. Nyberg, M. Engström et al., “Immunological
changes in human skeletal muscle and blood after eccentric
exercise and multiple biopsies,” Journal of Physiology, vol. 529,
no. 1, pp. 243–262, 2000.
[34] G. Paulsen, R. Crameri, H. B. Benestad et al., “Time course
of leukocyte accumulation in human muscle after eccentric
exercise,” Medicine and Science in Sports and Exercise, vol. 42,
no. 1, pp. 75–85, 2010.
[35] D. C. Nieman, J. M. Davis, V. A. Brown et al., “Influence
of carbohydrate ingestion on immune changes after 2 h of
intensive resistance training,” Journal of Applied Physiology, vol.
96, no. 4, pp. 1292–1298, 2004.
[36] J. Jordan, R. Beneke, M. Hütler, A. Veith, H. Haller, and F. C.
Luft, “Moderate exercise leads to decreased expression of 𝛽1
and 𝛽2 integrins on leucocytes,” European Journal of Applied
Physiology and Occupational Physiology, vol. 76, no. 2, pp. 192–
194, 1997.
[37] J. Peake, J. J. Peiffer, C. R. Abbiss et al., “Body temperature
and its effect on leukocyte mobilization, cytokines and markers
of neutrophil activation during and after exercise,” European
Journal of Applied Physiology, vol. 102, no. 4, pp. 391–401, 2008.

Mediators of Inflammation
[38] S. Gordon and P. R. Taylor, “Monocyte and macrophage heterogeneity,” Nature Reviews Immunology, vol. 5, no. 12, pp. 953–964,
2005.
[39] F. Montecucco, S. Steffens, F. Burger, G. Pelli, C. Monaco, and F.
Mach, “C-reactive protein (CRP) induces chemokine secretion
via CD11b/ICAM-1 interaction in human adherent monocytes,”
Journal of Leukocyte Biology, vol. 84, no. 4, pp. 1109–1119, 2008.
[40] R. Mittal, I. Gonzalez-Gomez, A. Panigrahy, K. Goth, R. Bonnet,
and N. V. Prasadarao, “IL-10 administration reduces PGE-2
levels and promotes CR3-mediated clearance of Escherichia
coli K1 by phagocytes in meningitis,” Journal of Experimental
Medicine, vol. 207, no. 6, pp. 1307–1319, 2010.
[41] A. Ohsaka, K. Saionji, T. Kuwaki, T. Takeshima, and J. Igari,
“Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human
monocytes,” British Journal of Haematology, vol. 89, no. 3, pp.
465–472, 1995.
[42] R. De Waal Malefyt, J. Abrams, B. Bennett, C. G. Figdor, and
J. E. De Vries, “Interleukin 10(IL-10) inhibits cytokine synthesis
by human monocytes: an autoregulatory role of IL-10 produced
by monocytes,” Journal of Experimental Medicine, vol. 174, no.
5, pp. 1209–1220, 1991.
[43] M. A. Cassatella, L. Meda, S. Bonora, M. Ceska, and G.
Constantin, “Interleukin 10 (IL-10) inhibits the release of
proinflammatory cytokines from human polymorphonuclear
leukocytes. Evidence for an autocrine role of tumor necrosis
factor and IL-1𝛽 in mediating the production of IL-8 triggered
by lipopolysaccharide,” Journal of Experimental Medicine, vol.
178, no. 6, pp. 2207–2211, 1993.

9

MEDIATORS
of

INFLAMMATION

The Scientific
World Journal
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Gastroenterology
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Hindawi Publishing Corporation
http://www.hindawi.com

Diabetes Research
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

International Journal of

Journal of

Endocrinology

Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com

Disease Markers

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Submit your manuscripts at
http://www.hindawi.com
BioMed
Research International

PPAR Research
Hindawi Publishing Corporation
http://www.hindawi.com

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Journal of

Obesity

Journal of

Ophthalmology
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Evidence-Based
Complementary and
Alternative Medicine

Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Oncology
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Parkinson’s
Disease

Computational and
Mathematical Methods
in Medicine
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

AIDS

Behavioural
Neurology
Hindawi Publishing Corporation
http://www.hindawi.com

Research and Treatment
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Oxidative Medicine and
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

